Testing and reporting ACMG cystic fibrosis mutation panel results

Genetic Testing

Volumn 11, Issue 1, 2007, Pages 11-31

  Lebo, Roger V ^a,b   Grody, Wayne W ^c  

^a AKRON CHILDREN'S HOSPITAL   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CFTR GENE; CLINICAL FEATURE; CYSTIC FIBROSIS; DNA DETERMINATION; ETHNIC DIFFERENCE; GENE MUTATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMAN; MUTATIONAL ANALYSIS; PEDIGREE ANALYSIS; PRENATAL DIAGNOSIS; REGULATOR GENE; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS;

CYSTIC FIBROSIS; FEMALE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; LIKELIHOOD FUNCTIONS; MALE; PEDIGREE; PREGNANCY; PRENATAL DIAGNOSIS; RISK;

EID: 34147125373     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2006.9996     Document Type: Review

References (21)

1. Cardwell J (2006) Nurse checks in. Akron Beacon Journal, Section B, Page 1, Column 1, bottom. February 25 newspaper issue.
2. Cerda-Flores RM, Barton SA, Marty-Gonzalez LF, Rivas F, Chakraborty R (1999) Estimation of nonpaternity in the Mexican population of Nuevo Leon: a validation study with blood group markers. Am J Phys Anthropol 109:281-293.
3. Claustres M, Guittard C, Bozon D, Chevalier F, Verlingue C, Ferec C, Girodon E, Cazeneuve C, Bienvenu T, Lalau G, Dumur V, Feldmann D, Bieth E, Blavau M, Clavel C, Creveaux I, Malinge MC, Monnier N, Malzac P, Mittre H, Chomel JC, Bonnefont JP, Iron A, Chery M, Georges MD (2000) Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France. Hum Mutat 16:143-156.
4. Curtis A, Richardson RJ, Boohene J, Jackson A, Nelson R, Bhattacharya SS (1993) Absence of cystic fibrosis mutations in a large Asian population sample and occurrence of a homozygous S549N in an inbred Pakistani family. J Med Genet 30:164-166.
5. Cystic Fibrosis Mutation Database http://www.genet.sickkids.on.ca/cftr/.
6. Dugueperoux I, Hubert D, Dominique S, Bellis G, De Braekeleer M, Durieu I (2006) Paternity in men with cystic fibrosis: a retrospective survey in France. J Cyst Fibros, Apr 17. [Epub ahead of print]
7. Grody WW (2001) Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ; Subcommittee on Cystic Fibrosis Screening, Accreditation of Genetic Services Committee, ACMG. American College of Medical Genetics. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 3:149-154.
8. Grody W (2003) Genetic engineering. Paper presented at Developing QC Materials for Genetic Testing Workshop. Center for Disease Control and Dept. Health and Human Services, pp. 3-1 to 3-11, Atlanta, GA. September 15-16.
9. Heim RA, Sugarman EA, Allitto BA (2001) Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel. Genet Med 3:168-176.
10. Lebo RV, Maher T, Farrer L, Yosunkaya Fenerci E, Milunsky J (2001) Highly polymorphic short tandem repeat analyses clarify complex molecular test results. Diagn Mol Pathol 10:179-189.
11. Lebo RV, Dunphy G, Quicci M, Galehouse D (2003) Multiple synthesized control mutations optimize clinical test quality. Am J Hum Genet 73(suppl):414.
12. Lebo RV, Dunphy G, Quicci M, Galehouse D (2003) Synthesized multiple control DNA sequences optimize genomic test quality control. In: Developing QC Materials for Genetic testing. Center for Disease Control and Dept. Health and Human Services, pp. 6-1 to 6-5, Atlanta, GA. September 15-16
13. Lebo RV, Wyandt H, Milunsky A (2004) Defining DNA Diagnostic screening tests appropriate for standard-of-care. Am J Hum Genet 75(suppl):278.
14. Massie RJ, Poplawski N, Wilcken B, Goldblatt J, Byrnes C, Robertson C (2001) Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C. Eur Respir J 17:1195-1200.
15. Oates RD, Amos JA (1994) The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. J Androl 15:1-8.
16. Okada H, Yoshimura K, Fujioko H, Tatsumi N, Gotoh A, Fujisawa M, Gohji K, Arakawa S, Kato H, Kobayashi ST, Isojima S, Koshida M, Kamidono S (1999) Assisted reproduction technology for patients with congenital bilateral absence of vas deferens. J Urol 161:1157-1162.
17. OMIM. Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/ Omim/ (for CF and CBAVD).
18. Palomaki GE, Bradley LA, Richards CS, Haddow JE (2003) Analytic validity of cystic fibrosis testing: a preliminary estimate. Genet Med 5:15-20.
19. Teng H, Jorissen M, Van Poppel H, Legius E, Cassiman JJ, Cuppens H (1997) Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells. Hum Mol Genet 6:85-90.
20. Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger D, Mennuti M, Palomaki GE, Propvich BW, Pratt VM, Rohlfs EM, Strom CM, Richards CS, Witt DR, Grody WW (2004) Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 6:387-391.
21. Sasse G, Muller H, Chakraborty R, Ott J (1994) Estimating the frequency of nonpaternity in Switzerland. Hum Hered. 44:337-343.